Real‐world safety and efficacy data of ipilimumab in Japanese radically unresectable malignant melanoma patients: A postmarketing surveillance

Treatment with immune checkpoint inhibitors has improved prognosis among patients with cutaneous melanoma, but there are still unmet medical needs in Japan, especially for mucosal melanoma and acral lentiginous melanoma (ALM) subtypes. Ipilimumab, a fully human monoclonal antibody that specifically...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamazaki, Naoya, Kiyohara, Yoshio, Uhara, Hisashi, Tsuchida, Tetsuya, Maruyama, Keiko, Shakunaga, Naoki, Itakura, Eijun, Komoto, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496696/
https://www.ncbi.nlm.nih.gov/pubmed/32515086
http://dx.doi.org/10.1111/1346-8138.15388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496696/
https://www.ncbi.nlm.nih.gov/pubmed/32515086
http://dx.doi.org/10.1111/1346-8138.15388

Ejemplares similares